在代谢功能障碍相关的脂肪性肝病中,阿洛普诺的作用:一项随机临床试验
Elnaz Khani1, Manouchehr Khoshbaten2, Mohammad Asghari Jafarabadi3
1Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
概括
与基线相比,阿洛普林醇改善了代谢功能障碍相关的脂肪性肝病 (MASLD) 患者的肝酶和超声波分级. 然而,与对照组相比,这些好处并没有显著不同.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 内部医学 内部医学
- 临床试验 临床试验
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 是肝脏死亡的主要原因,具有具有挑战性的治疗选择.
- 尿酸在MASLD的发病过程中发挥着重要作用,这表明了潜在的治疗点.
研究的目的:
- 评估阿洛普林醇在改善MASLD患者肝酶和超声波分级方面的疗效.
- 评估MASLD患者血清尿酸水平和肝酶之间的相关性.
主要方法:
- 一个为期6个月的随机临床试验,涉及104名MASLD患者.
- 患者接受了阿洛普里诺 (100毫克每天) 加上低热量饮食或单独的低热量饮食.
- 结果包括超声波分级和阿斯巴酸胺酶 (AST) 和氨酸胺酶 (ALT) 的血清水平,使用基平方测试和ANCOVA进行分析.
主要成果:
- 与基线 (P = 0.001) 相比,阿洛普林醇组的超声波分级显著改善 (P = 0.001).
- 在阿洛普林醇组内,ALT和AST水平与基线相比显著下降 (P = 0.004和P = 0.022,分别).
- 血清尿酸与6个月后在Allopurinol治疗组的ALT和AST水平相关.
结论:
- 与MASLD患者的基线相比,Allopurinol的使用显示了超声波分级和肝酶的改善.
- 然而,与对照组相比,该研究没有发现与对照组相比,阿洛普林醇的统计学上显著的有益影响.
相关概念视频
01:16Clinical Trials
10.4K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.4K
01:11Clinical Trials: Overview
4.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.9K
01:12Statistical Software for Data Analysis and Clinical Trials
1.5K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.5K
01:26Diseases of the Liver and Gallbladder
2.0K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.0K
01:24Chronic Kidney Disease II: Clinical Manifestations
641
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
641
00:52What is Metabolism?
131.7K
Overview
131.7K